PCSK9 and coronary artery disorder: Ikegami et al. considered the effects of PCSK9 inhibitors on CAC scores in 120 patients, 60% of whom had a past history of CAD, that were divided into three groups (no therapy, statin therapy alone and dual therapy with a statin and PCSK9 inhibitor) [53].